Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Target organ damage more pronounced in patients with primary aldosteronism

06 Jan 2020

Target organ damage appears to be more noticeable in patients affected by primary aldosteronism than those affected by arterial hypertension without primary aldosteronism, suggests a study, adding that specific treatment can ease such condition.

A quantitative review was performed on studies that assessed the parameters of renal function in patients affected by primary aldosteronism vs arterial hypertension without primary aldosteronism and in patients affected by primary aldosteronism before and after treatment.

The databases of Medline, Embase and the Cochrane Central Register of Controlled Trials were searched from January 1960 up to April 2019. Forty-six studies, which included 6,056 patients with primary aldosteronism and 9,733 patients affected by arterial hypertension without primary aldosteronism, met the eligibility criteria.

The estimated glomerular filtration rate (eGFR) was increased by 3.37 ml/min (interquartile range [IQR], 0.82–5.93) in patients with primary aldosteronism compared with hypertensive individuals without primary aldosteronism after 8.5 years from hypertension diagnosis. The former also had a more severe albuminuria (standard mean difference, 0.55; IQR, 0.19–0.91), which led to a correlation with microalbuminuria (odds ratio [OR], 2.09, 95 percent confidence interval [CI], 1.40–3.12) and proteinuria (OR, 2.68, 95 percent CI, 1.89–3.79).

After a median follow-up of 12 months, eGFR decreased by –10.69 ml/min (IQR, –13.23 to –8.16) following primary aldosteronism treatment. This was consistent in both medically and surgically treated patients. Likewise, albumin excretion decreased and serum creatinine increased after treatment.

“In experimental animal models, exogenous aldosterone excess has been linked to the progression of renal disease,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.